{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T11:05:29Z","timestamp":1779447929910,"version":"3.53.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Yunnan Provincial Department of Science and Technology Key Research and Development Program","award":["202403AC100001"],"award-info":[{"award-number":["202403AC100001"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gastrointest Canc"],"DOI":"10.1007\/s12029-026-01495-x","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T10:16:01Z","timestamp":1779444961000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Total Neoadjuvant Therapy Versus Neoadjuvant Chemotherapy Alone for High-Risk Locally Advanced Rectal Cancer: a Propensity Score Matched Study"],"prefix":"10.1007","volume":"57","author":[{"given":"Chaoxian","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Cha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shulian","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kun","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"1495_CR1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21834","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clin"},{"key":"1495_CR2","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000000553","author":"Q Wei","year":"2023","unstructured":"Wei Q, Wei ZQ, Jing CQ, et al. Incidence, prevention, risk factors, and prediction of venous thromboembolism in Chinese patients after colorectal cancer surgery: a prospective, multicenter cohort study. Int J Surg. 2023. https:\/\/doi.org\/10.1097\/JS9.0000000000000553.","journal-title":"Int J Surg"},{"key":"1495_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2023.103992","author":"IM Koukourakis","year":"2023","unstructured":"Koukourakis IM, Kouloulias V, Tiniakos D, et al. Current status of locally advanced rectal cancer therapy and future prospects. Crit Rev Oncol Hematol. 2023. https:\/\/doi.org\/10.1016\/j.critrevonc.2023.103992.","journal-title":"Crit Rev Oncol Hematol"},{"key":"1495_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00120-5","author":"AL Appelt","year":"2015","unstructured":"Appelt AL, Pl\u00f8en J, Harling H, et al. High-dose chemoradiotherapy and watchful waiting for distal rectal cancer: a prospective observational study. Lancet Oncol. 2015. https:\/\/doi.org\/10.1016\/S1470-2045(15)00120-5.","journal-title":"Lancet Oncol"},{"key":"1495_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000257358.56863.ce","author":"KC Peeters","year":"2007","unstructured":"Peeters KC, Marijnen CA, Nagtegaal ID, et al. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg. 2007. https:\/\/doi.org\/10.1097\/01.sla.0000257358.56863.ce.","journal-title":"Ann Surg"},{"key":"1495_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(20)30555-6","author":"RR Bahadoer","year":"2021","unstructured":"Bahadoer RR, Dijkstra EA, van Etten B, et al. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial. Lancet Oncol. 2021. https:\/\/doi.org\/10.1016\/S1470-2045(20)30555-6.","journal-title":"Lancet Oncol"},{"key":"1495_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(21)00079-6","author":"T Conroy","year":"2021","unstructured":"Conroy T, Bosset JF, Etienne PL, et al. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial. Lancet Oncol. 2021. https:\/\/doi.org\/10.1016\/S1470-2045(21)00079-6.","journal-title":"Lancet Oncol"},{"key":"1495_CR8","doi-asserted-by":"publisher","unstructured":"Conroy T, Etienne P, Rio E, et al. Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiation in patients with locally advanced rectal cancer: 7-year results of PRODIGE 23 phase III trial, a UNICANCER GI trial. J Clin Oncol. 2026;41(J Clin Oncol). https:\/\/doi.org\/10.1200\/jco.2023.41.17_suppl.lba3504.","DOI":"10.1200\/jco.2023.41.17_suppl.lba3504"},{"key":"1495_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000005799","author":"EA Dijkstra","year":"2023","unstructured":"Dijkstra EA, Nilsson PJ, Hospers GAP, et al. Locoregional failure during and after short-course radiotherapy followed by chemotherapy and surgery compared with long-course chemoradiotherapy and surgery: a 5-year follow-up of the RAPIDO trial. Ann Surg. 2023. https:\/\/doi.org\/10.1097\/SLA.0000000000005799.","journal-title":"Ann Surg"},{"key":"1495_CR10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01667","author":"J Jin","year":"2022","unstructured":"Jin J, Tang Y, Hu C, et al. Multicenter, randomized, Phase III trial of short-term radiotherapy plus chemotherapy versus long-term chemoradiotherapy in locally advanced rectal cancer (STELLAR). J Clin Oncol. 2022. https:\/\/doi.org\/10.1200\/JCO.21.01667.","journal-title":"J Clin Oncol"},{"key":"1495_CR11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.24.01160","author":"AJ Scott","year":"2024","unstructured":"Scott AJ, Kennedy EB, Berlin J, et al. Management of locally advanced rectal cancer: ASCO guideline. J Clin Oncol. 2024. https:\/\/doi.org\/10.1200\/JCO.24.01160.","journal-title":"J Clin Oncol"},{"key":"1495_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70026-7","author":"HJ Andreyev","year":"2010","unstructured":"Andreyev HJ, Wotherspoon A, Denham JW, et al. Defining pelvic-radiation disease for the survivorship era. Lancet Oncol. 2010. https:\/\/doi.org\/10.1016\/S1470-2045(10)70026-7.","journal-title":"Lancet Oncol"},{"key":"1495_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2023.100656","author":"V Vesa","year":"2023","unstructured":"Vesa V, Jaana M, Ia K, et al. Short-course preoperative radiotherapy increases pelvic fracture risk in rectal cancer. Clin Transl Radiat Oncol. 2023. https:\/\/doi.org\/10.1016\/j.ctro.2023.100656.","journal-title":"Clin Transl Radiat Oncol"},{"key":"1495_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70061-4","author":"A Berrington de Gonzalez","year":"2011","unstructured":"Berrington de Gonzalez A, Curtis RE, Kry SF, et al. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol. 2011. https:\/\/doi.org\/10.1016\/S1470-2045(11)70061-4.","journal-title":"Lancet Oncol"},{"key":"1495_CR15","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000000665","author":"Q Qin","year":"2016","unstructured":"Qin Q, Ma T, Deng Y, et al. Impact of preoperative radiotherapy on anastomotic leakage and stenosis after rectal cancer resection: post hoc analysis of a randomized controlled trial. Diseases of the Colon & Rectum. 2016. https:\/\/doi.org\/10.1097\/DCR.0000000000000665.","journal-title":"Diseases of the Colon & Rectum"},{"key":"1495_CR16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.18.02309","author":"Y Deng","year":"2019","unstructured":"Deng Y, Chi P, Lan P, et al. Neoadjuvant modified FOLFOX6 with or without radiation versus fluorouracil plus radiation for locally advanced rectal cancer: final results of the Chinese FOWARC trial. J Clin Oncol. 2019. https:\/\/doi.org\/10.1200\/JCO.18.02309.","journal-title":"J Clin Oncol"},{"key":"1495_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-024-02652-4","author":"J Cai","year":"2024","unstructured":"Cai J, Lin K, Luo T, et al. Neoadjuvant chemotherapy is noninferior to chemoradiotherapy for early-onset locally advanced rectal cancer in the FOWARC trial. Br J Cancer. 2024. https:\/\/doi.org\/10.1038\/s41416-024-02652-4.","journal-title":"Br J Cancer"},{"key":"1495_CR18","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa2303269","author":"D Schrag","year":"2023","unstructured":"Schrag D, Shi Q, Weiser MR, et al. Preoperative treatment of locally advanced rectal cancer. N Engl J Med. 2023. https:\/\/doi.org\/10.1056\/NEJMoa2303269.","journal-title":"N Engl J Med"},{"key":"1495_CR19","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000005780","author":"WJ Mei","year":"2023","unstructured":"Mei WJ, Wang XZ, Li YF, et al. Neoadjuvant chemotherapy with CAPOX versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): initial results of a phase III trial. Ann Surg. 2023. https:\/\/doi.org\/10.1097\/SLA.0000000000005780.","journal-title":"Ann Surg"},{"key":"1495_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.annonc.2023.10.018","author":"P Ding","year":"2026","unstructured":"Ding P, Wang X, Li Y, et al. LBA26 Neoadjuvant chemotherapy with CAPOX versus chemoradiation for locally advanced rectal cancer with uninvolved mesorectal fascia (CONVERT): Final results of a phase III trial. Ann Oncol. 2026. https:\/\/doi.org\/10.1016\/j.annonc.2023.10.018. 34 Ann Oncol.","journal-title":"Ann Oncol"},{"key":"1495_CR21","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.23.01208","author":"FS Verheij","year":"2024","unstructured":"Verheij FS, Omer DM, Williams H, et al. Long-term results of organ preservation in patients with rectal adenocarcinoma treated with total neoadjuvant therapy: the randomized Phase II OPRA trial. J Clin Oncol. 2024. https:\/\/doi.org\/10.1200\/JCO.23.01208.","journal-title":"J Clin Oncol"},{"key":"1495_CR22","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.70222","author":"R Zhang","year":"2025","unstructured":"Zhang R, Wang F, Jiang X, et al. Short-term results of the SONCAR study: optimized neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients. MedComm. 2025. https:\/\/doi.org\/10.1002\/mco2.70222.","journal-title":"MedComm"},{"key":"1495_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.953790","author":"X Zhao","year":"2022","unstructured":"Zhao X, Han P, Zhang L, et al. Prolonged neoadjuvant chemotherapy without radiation versus total neoadjuvant therapy for locally advanced rectal cancer: a propensity score matched study. Front Oncol. 2022. https:\/\/doi.org\/10.3389\/fonc.2022.953790.","journal-title":"Front Oncol"},{"key":"1495_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-023-04779-y","author":"J Wu","year":"2023","unstructured":"Wu J, Huang M, Wu Y, et al. Neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy alone for patients with locally advanced rectal cancer: a propensity-score-matched analysis combined with SEER validation. J Cancer Res Clin Oncol. 2023. https:\/\/doi.org\/10.1007\/s00432-023-04779-y.","journal-title":"J Cancer Res Clin Oncol"},{"key":"1495_CR25","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.19.00308","author":"E Fokas","year":"2019","unstructured":"Fokas E, Allg\u00e4uer M, Polat B, et al. Randomized Phase II trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO\/ARO\/AIO-12. J Clin Oncol. 2019. https:\/\/doi.org\/10.1200\/JCO.19.00308.","journal-title":"J Clin Oncol"},{"key":"1495_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2015.04.010","author":"CP Probst","year":"2015","unstructured":"Probst CP, Becerra AZ, Aquina CT, et al. Extended intervals after neoadjuvant therapy in locally advanced rectal cancer: the key to improved tumor response and potential organ preservation. J Am Coll Surg. 2015. https:\/\/doi.org\/10.1016\/j.jamcollsurg.2015.04.010.","journal-title":"J Am Coll Surg"},{"key":"1495_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)00004-2","author":"J Garcia-Aguilar","year":"2015","unstructured":"Garcia-Aguilar J, Chow OS, Smith DD, et al. Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. The Lancet Oncology. 2015. https:\/\/doi.org\/10.1016\/S1470-2045(15)00004-2.","journal-title":"The Lancet Oncology"},{"key":"1495_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/DCR.0000000000001207","author":"MR Marco","year":"2018","unstructured":"Marco MR, Zhou L, Patil S, et al. Consolidation mFOLFOX6 chemotherapy after chemoradiotherapy improves survival in patients with locally advanced rectal cancer: final results of a multicenter phase II trial. Diseases of the Colon & Rectum. 2018. https:\/\/doi.org\/10.1097\/DCR.0000000000001207.","journal-title":"Diseases of the Colon & Rectum"},{"key":"1495_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.gassur.2024.07.015","author":"K Erozkan","year":"2024","unstructured":"Erozkan K, Elamin D, Tasci ME, et al. Evaluating complete response rates and predictors in total neoadjuvant therapy for rectal cancer. J Gastrointest Surg. 2024. https:\/\/doi.org\/10.1016\/j.gassur.2024.07.015.","journal-title":"J Gastrointest Surg"},{"key":"1495_CR30","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2025.21197","author":"K Sugumar","year":"2025","unstructured":"Sugumar K, Lie JJ, Stucky CC, et al. Pathologic complete response and survival in rectal cancer: a systematic review and meta-analysis. JAMA Netw Open. 2025. https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.21197.","journal-title":"JAMA Netw Open"},{"key":"1495_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.03.010","author":"K Bruheim","year":"2010","unstructured":"Bruheim K, Guren MG, Skovlund E, et al. Late side effects and quality of life after radiotherapy for rectal cancer. Int J Radiat Oncol Biol Phys. 2010. https:\/\/doi.org\/10.1016\/j.ijrobp.2009.03.010.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"1495_CR32","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.256","author":"CA Marijnen","year":"2005","unstructured":"Marijnen CA, van de Velde CJ, Putter H, et al. Impact of short-term preoperative radiotherapy on health-related quality of life and sexual functioning in primary rectal cancer: report of a multicenter randomized trial. J Clin Oncol. 2005. https:\/\/doi.org\/10.1200\/JCO.2005.05.256.","journal-title":"J Clin Oncol"},{"key":"1495_CR33","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-017-2875-8","author":"W Zhang","year":"2017","unstructured":"Zhang W, Lou Z, Liu Q, et al. Multicenter analysis of risk factors for anastomotic leakage after middle and low rectal cancer resection without diverting stoma: a retrospective study of 319 consecutive patients. Int J Colorectal Dis. 2017. https:\/\/doi.org\/10.1007\/s00384-017-2875-8.","journal-title":"Int J Colorectal Dis"},{"key":"1495_CR34","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e31827b8ed9","author":"JS Park","year":"2013","unstructured":"Park JS, Choi GS, Kim SH, et al. Multicenter analysis of risk factors for anastomotic leakage after laparoscopic rectal cancer excision: the Korean laparoscopic colorectal surgery study group. Ann Surg. 2013. https:\/\/doi.org\/10.1097\/SLA.0b013e31827b8ed9.","journal-title":"Ann Surg"},{"key":"1495_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/nu10101405","author":"T Kumagai","year":"2018","unstructured":"Kumagai T, Rahman F, Smith AM. The microbiome and radiation induced-bowel injury: evidence for potential mechanistic role in disease pathogenesis. Nutrients. 2018. https:\/\/doi.org\/10.3390\/nu10101405.","journal-title":"Nutrients"},{"key":"1495_CR36","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2559.1985.tb02833.x","author":"PS Hasleton","year":"1985","unstructured":"Hasleton PS, Carr N, Schofield PF. Vascular changes in radiation bowel disease. HISTOPATHOLOGY. 1985. https:\/\/doi.org\/10.1111\/j.1365-2559.1985.tb02833.x.","journal-title":"HISTOPATHOLOGY"},{"key":"1495_CR37","doi-asserted-by":"publisher","DOI":"10.1111\/codi.15997","author":"M Degiuli","year":"2022","unstructured":"Degiuli M, Elmore U, De Luca R, et al. Risk factors for anastomotic leakage after anterior resection for rectal cancer (RALAR study): a nationwide retrospective study of the Italian Society of Surgical Oncology Colorectal Cancer Network Collaborative Group. Colorectal Disease. 2022. https:\/\/doi.org\/10.1111\/codi.15997.","journal-title":"Colorectal Disease"},{"key":"1495_CR38","doi-asserted-by":"publisher","DOI":"10.1097\/JS9.0000000000004528","author":"Y Cao","year":"2025","unstructured":"Cao Y, Wu A, Wu Z, et al. Prophylactic ileostomy vs. nonprophylactic ileostomy in laparoscopic low anterior resection for rectal cancer (PILLAR): a prospective, multicenter, cohort study in China. INT J SURG. 2025. https:\/\/doi.org\/10.1097\/JS9.0000000000004528.","journal-title":"INT J SURG"},{"key":"1495_CR39","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2010.11.003","author":"L Sharpe","year":"2011","unstructured":"Sharpe L, Patel D, Clarke S. The relationship between body image disturbance and distress in colorectal cancer patients with and without stomas. J Psychosom Res. 2011. https:\/\/doi.org\/10.1016\/j.jpsychores.2010.11.003.","journal-title":"J Psychosom Res"},{"key":"1495_CR40","doi-asserted-by":"publisher","DOI":"10.1007\/s00384-020-03771-z","author":"NZ Ahmad","year":"2021","unstructured":"Ahmad NZ, Abbas MH, Khan SU, et al. A meta-analysis of the role of diverting ileostomy after rectal cancer surgery. Int J Colorectal Dis. 2021. https:\/\/doi.org\/10.1007\/s00384-020-03771-z.","journal-title":"Int J Colorectal Dis"},{"key":"1495_CR41","doi-asserted-by":"publisher","DOI":"10.1177\/00469580231212126","author":"U Dahlstrand","year":"2023","unstructured":"Dahlstrand U, Gustafsson P, N\u00e4svall P, et al. Costs related to diverting ileostomy after rectal cancer surgery: a population-based healthcare cost analysis based on nationwide registers. Inquiry. 2023. https:\/\/doi.org\/10.1177\/00469580231212126.","journal-title":"Inquiry"}],"container-title":["Journal of Gastrointestinal Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01495-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12029-026-01495-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12029-026-01495-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T10:16:02Z","timestamp":1779444962000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12029-026-01495-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1495"],"URL":"https:\/\/doi.org\/10.1007\/s12029-026-01495-x","relation":{},"ISSN":["1941-6636"],"issn-type":[{"value":"1941-6636","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"5 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted in accordance with the Declaration of Helsinki, and approved by the Ethics Committee of Yunnan Cancer Hospital (protocol code KYLX2026-042 and date of approval 2026-01-25).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics\u00a0Approval"}},{"value":"Verbal consent was obtained from the cases included in the study by calling the contact numbers registered in the system.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"122"}}